United Therapeutics CEO sold 9,500 shares under plan
What happened Martine A. Rothblatt, chairperson, CEO and a director of United Therapeutics Corp (NASDAQ: UTHR), sold 9,500 shares on 2026-09-28. She sold them at prices from $472.43 to $486.00 per share, for about $4.57 million in total. The Form 4 says the trades were made under a Rule 10b5-1 trading plan adopted on November […]
2 Oct 05:01 · The Markets Daily